The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> MEDICINE >> NEWS
Major advance in chemotherapy in breast cancer

San Antonio, TX December 5, 2003 A Docetaxel (Taxotere)-based regimen reduced the relative risk of death in women with early stage breast cancer by 30 percent and lowered the relative risk of the cancer returning by 28 percent when compared to a standard adjuvant (post-surgery) regimen after 55-month follow-up. The results of BCIRG 001, the first phase III study evaluating Taxotere after breast surgery, were presented at the San Antonio Breast Cancer Symposium (SABCS) by the Breast Cancer International Research Group (BCIRG) today.

"Taxotere continues to demonstrate its effectiveness across various stages of breast cancer, and this study indicates that women with early stage breast cancer and their physicians should seriously consider a Taxotere-based treatment, like the TAC regimen tested in the BCIRG 001 trial, to significantly prolong disease-free survival and survival," said Miguel Martin M.D. from the Medical Oncology Department, Hospital Universitario San Carlos, Madrid, Spain, chairman of GEICAM.

Study Design
The BCIRG 001 study was designed to determine if Taxotere, one of the most active agents in advanced breast cancer, would also have benefits for women with early stage disease. Study participants received either a post-surgery regimen of Taxotere, doxorubicin (Adriamycin), and cyclophosphamide (Cytoxan), known as TAC, or the widely used standard regimen of 5-fluorouracil, doxorubicin and cyclophosphamide, known as FAC. BCIRG 001 enrolled 1,491 pre- and post-menopausal women with early breast cancer at 111 sites in 20 countries; 745 patients were randomized to receive TAC and 746 to receive FAC. The study was designed to perform analyses on subgroups of women based on hormonal receptor status (hormone-receptor-positive or hormone-receptor-negative tumors) and nodal involvement (one-to-three or four-plus axillary lymph nodes). Tumor samples were prospectively collected for 95 percent of the patients. Hormonal receptor s
'"/>

Contact: Arleen Goldenberg
arleen_goldenberg@nyc.cohnwolfe.com
212-798-9749
Cohn & Wolfe
5-Dec-2003


Page: 1 2 3 4

Related medicine news :

1. Major review of subway systems suggests potential for significant health and safety hazards
2. Major step forwards for vaccine against cervical cancer
3. Majority of cigarettes in the US smoked by nicotine-dependent or psychiatrically ill persons
4. Major overhaul needed in end-of life care for patients with dementia
5. Major overhaul needed in end-of life care for patients with dementia
6. Major radiology journal offers unrestricted access to recently archived articles
7. Major study: Bioartificial liver reduces mortality by 44 percent in acute liver-failure patients
8. Majority of authors retract 1998 Lancet paper-Lancet editor points to implications
9. Major agreement reached at heart health conference
10. Major risk factors identified for sudden infant death syndrome
11. Major cause of painful gastroenteritis under study at MCG

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Major advance chemotherapy breast cancer

(Date:11/25/2009)...o signaling pathways essential to normal human dev...owth factor receptor (EGFR) pathways - interact in...astasis, researchers from The University of Texas ... issue of Molecular Cell . , This newly charact...ents known to correlate with invasive cancer - act...
(Date:11/25/2009)...ov. 25, 2009) Melvin R. Kaplan, MD, FACP, a forme...rch institute that became Los Angeles Biomedical R...A BioMed), will be honored by the American College...re of patients. , At its April 22, 2010 meeting ...l present Dr. Kaplan with the Ralph O. Claypoole S...
(Date:11/25/2009)...5, 2009 Physicians at UT Southwestern Medical Cen...ed to improve breathing in patients with upper spi... from breathing independently. , UT Southwester...y two sites in Texas and one of 25 in the country ...he NeuRx Diaphragm Pacing System. , The device i...
(Date:11/25/2009)...tify role mitochondrial function plays in insulin ...hDay News) -- Mitochondrial damage causes people w...s, a finding that could lead to new treatments, U....gy for cellular activity. , The researchers fou...ancreas can,t respond to circulating insulin, it t...
(Date:11/25/2009)... PCU College teaches students to use natu... , Burnaby, BC (Vocus) No... radiation are the standard, effective treatments ...o alternative medicine to help them cope with the ...creased number of cancer patients using acupunctur...
Breaking Medicine News(10 mins):Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 2Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 3Health News:1 of LA BioMed's founders to be honored 2Health News:New device implanted by surgeons help paralyzed patients breathe easier 2Health News:Holistic and Western Medicine Combined Can Fight Cancer 2
(Date:11/25/2009)...DIEGO,Nov.25/PRNewswire-FirstCall/--NuVasive,Inc.(...opingproductsforminimallydisruptivesurgicaltreatme...encecallonMonday,November30,2009,at5:30p.m.ET/2:30...lativetoreimbursementfortheCompany,sproductsandwil...tionandanswersession.Thedial-innumbersare1-877-407...
(Date:11/25/2009)...MINGHAM,Mass.andSYDNEY,Nov.25/PRNewswire-FirstCall...IN),aleadinginnovatorandprovideroflessinvasive,min...zingthetreatmentofadvancedheartfailure,todayannoun...the21stAnnualPiperJaffrayHealthCareConferenceat8:0...ingheldattheNewYorkPalaceHotel,December1-2. ,, ...
(Date:11/24/2009)...ISON,N.J.,Nov.24/PRNewswire-FirstCall/--QuestDiagn...oviderofdiagnostictesting,informationandservices,a...erJaffrayHealthcareConferenceinNewYorkCity.Thepres...30a.m.EasternTime. ,, Duringtheconference,theco...approximate3%,operatingincometoexceed18%ofrevenues...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2EnVivo Pharmaceuticals Announces Results and Successful Completion of EVP 6124 Phase Ib IIa Trial at the International Conference on Alzheimers Diseas 13042 1EnVivo Pharmaceuticals Announces Results and Successful Completion of EVP 6124 Phase Ib IIa Trial at the International Conference on Alzheimers Diseas 13042 2Rare Cells Linked to Pediatric Cancers 51764 1Rare Cells Linked to Pediatric Cancers 51764 2Stem Cell Decision Opens New Doors May Spur More Research 51762 1Stem Cell Decision Opens New Doors May Spur More Research 51762 2Stem Cell Decision Opens New Doors May Spur More Research 51762 3
Other News:
...heimer's disease....... When his father developed...ole of constant guardian and guide, helping her hu...hat most of us take for granted......."As my fathe...ther would give him gentle prompts to keep him on ...
...hink has been 'trained' by scientists to forecast ...iminary study involving 100 women, the system corr... whether the disease would spread to other parts o...ve years without a recurrence of cancer.......Dr G...
...t an appetite suppressant drug, D-fenfluramine (D-...intake and body weight. The NIH-funded study sugg...athways affecting appetite, obesity, and anorexia ...ight control. Results appear in the July 26, 2002,...
..., cheap, and effective treatment for people with f...r pain and joint tenderness), finds a study in thi...ents with fibromyalgia who were attending a hospit...ne 1998. Patients were then randomly assigned to e...
health news:University of Washington developing AI caretakers for Alzheimer's sufferers 2health news:University of Washington developing AI caretakers for Alzheimer's sufferers 3health news:University of Washington developing AI caretakers for Alzheimer's sufferers 4health news:Computer predicts outcome of breast cancer 2health news:Computer predicts outcome of breast cancer 3health news:Drug targets brain circuits that drive appetite and body weight 2
...ay a bigger role in your risk for heart disease th...at rural residents were more knowledgeable about h...sidents, but that urban residents were more motiva...her, these differences persisted when the research...
...ine, a drug that was believed could be beneficial ...ood pressure due to impaired cardiac function) aft...h up to six months after a heart attack, according...udy is being released early to coincide with its p...
... receive preventive health examinations, as oppose... appear more likely to undergo testing for colorec...eport in the March 26 issue of Archives of Interna...Preventive or periodic health examinationsalso cal...
Contrary to widespread belief, total surgical replacement of arthritic shoulder joints carries no greater risk of complications than replacement of other major joints, a Johns Hopkins study suggests.
health news:Place more than race tied to heart disease risk 2health news:Drug does not reduce risk of death for heart attack patients with refractory shock 2health news:Preventive health exams may provide opportunities for cancer screening 2health news:'Shrug off' shoulder surgery myth, study suggests 2health news:'Shrug off' shoulder surgery myth, study suggests 3